https://openbell.ai/ 2026-11-06T10:43:13.374Z hourly 1.0 https://openbell.ai/support 2026-11-06T10:43:13.374Z monthly 0.7 https://openbell.ai/privacy 2026-11-06T10:43:13.374Z monthly 0.5 https://openbell.ai/terms 2026-11-06T10:43:13.374Z monthly 0.5 https://openbell.ai/feed.json 2026-11-06T10:43:13.374Z hourly 0.8 https://openbell.ai/news/SUZ:1793961098000 2026-11-06T10:31:38.000Z daily 0.9 https://cdn.brandfetch.io/SUZ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Suzano Reports 36% Increase in Third Quarter Net Revenue Following Consolidation of Arbex Suzano reported record third-quarter 2026 net revenue of BRL 16.5 billion, up 36% year over year, primarily reflecting the first-time consolidation of Arbex, its 51%-owned joint venture with Kimberly-Clark. Adjusted EBITDA rose 9% on a comparable basis to R$ 5.7 billion, net income was R$ 2.1 billion, and operating cash generation increased 12% to R$ 3.8 billion. CEO Beto Abreu said Arbex’s integration expands Suzano’s geographic reach and product portfolio. https://openbell.ai/news/KYIV:1793959323000 2026-11-06T10:02:03.000Z daily 0.9 https://cdn.brandfetch.io/KYIV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Kyivstar Releases 3Q26 Results and Raises 2026 Outlook Kyivstar reported a return to profit in the third quarter of 2026, with revenue rising 17.5% year over year to $349 million (UAH 15.6 billion), up 26.5% in local currency. Telecommunications and infrastructure revenue grew 8.4% (16.7% in UAH), supported by higher mobile ARPU and data usage, while digital revenue also increased. The company raised its revenue outlook for fiscal 2026. https://openbell.ai/news/RMV:1793957519000 2026-11-06T09:31:59.000Z daily 0.9 https://cdn.brandfetch.io/RMV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Rightmove Updates 2026 Revenue Outlook and Provides 2027 Guidance Rightmove narrowed its 2026 revenue growth outlook to 6%–7%, from a previous range of 6%–8%, and expects revenue growth in 2027 to be similar. For 2027, it forecasts underlying operating profit growth of 4%–7% and underlying earnings-per-share growth of at least 10%. The company cited weak new-home building, affordability constraints and higher mortgage rates as headwinds weighing on homebuilder advertising demand. https://openbell.ai/news/DXRX:1793955708000 2026-11-06T09:01:48.000Z daily 0.9 https://cdn.brandfetch.io/DXRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Diaceutics Reports H1 2026 Financial and Operational Performance Diaceutics PLC reported a 20% increase in revenue in the first half of 2026. Annual Recurring Revenue reached GBP 29.4 million, with 149% net revenue retention and 6% gross ARR churn. The company said growth is supported by expanding its Precision for All and Relay initiatives, pursuing new pricing opportunities, and using AI to improve operational efficiency. https://openbell.ai/news/BILN:1793955706000 2026-11-06T09:01:46.000Z daily 0.9 https://cdn.brandfetch.io/BILN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Billington Holdings plc Issues Profit Warning for FY26 Billington Holdings plc cut its FY26 underlying profit-before-tax forecast to £4.0 million–£5.5 million, below market expectations of about £8.3 million. The revision reflects a material margin reduction on an industrial contract and client-led delays to the Tubecon bridge contract, whose contribution is now expected in 2027. Management said the issues are contract-specific and highlighted a record order book of approximately £120 million for 2026, a strong balance sheet and a substantial opportunities pipeline. https://openbell.ai/news/VTEX:1793955699000 2026-11-06T09:01:39.000Z daily 0.9 https://cdn.brandfetch.io/VTEX/w/400/h/400?c=1idopYfmtR7ZKg8QMud VTEX Reports Third Quarter 2026 Financial Results VTEX reported third-quarter 2026 revenue of $63.38 million, up 6.3% year over year. Operating profit increased 73.0% to $7.21 million, and operating margin improved to 11.4% from 7.0% a year earlier. Diluted EPS was $0.01. https://openbell.ai/news/2914:1793953913000 2026-11-06T08:31:53.000Z daily 0.9 https://cdn.brandfetch.io/2914/w/400/h/400?c=1idopYfmtR7ZKg8QMud Russian Government Places Japan Tobacco Assets Under Temporary Administration Russian President Vladimir Putin ordered Japan Tobacco’s Russian assets, including four factories, placed under the temporary administration of a local company. The move comes amid growing pressure from Moscow on Japan and Western countries over their support for Ukraine. The article reports no financial figures or stock-price impact. https://openbell.ai/news/OLE:1793952338000 2026-11-06T08:05:38.000Z daily 0.9 https://cdn.brandfetch.io/OLE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Deoleo Enters Binding Agreement to Sell Deoleo Holding to Acesur and Dcoop Deoleo signed a binding agreement to sell its main operating subsidiary, Deoleo Holding, to Spanish competitors Acesur and Dcoop. The transaction values the subsidiary at €520 million and covers a 91.99% stake, potentially rising to 100% depending on other shareholders’ participation. Deoleo expects to receive approximately €190 million to €200 million for its directly held 50.99% stake, subject to final adjustments. The deal would give Acesur and Dcoop indirect control of the business and reshape Spain’s olive oil sector. https://openbell.ai/news/HIK:1793952280000 2026-11-06T08:04:40.000Z daily 0.9 https://cdn.brandfetch.io/HIK/w/400/h/400?c=1idopYfmtR7ZKg8QMud SG Holding Increases Tender Offer Price for Haiki+ SG Holding, promoter of the tender offer for EGM-listed Haiki+ S.p.A., raised its offer price from €0.90 to €1.11 per share, an increase of 23.33%. The acceptance period has been extended to November 13, 2026, as the acquisition process continues. https://openbell.ai/news/ALTHE:1793952214000 2026-11-06T08:03:34.000Z daily 0.9 https://cdn.brandfetch.io/ALTHE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Theraclion Obtains FDA Authorization for Sonovein® Theraclion received FDA authorization for its Sonovein® system, which uses high-intensity focused ultrasound to treat varicose veins without incisions or anesthesia. The authorization allows the company to bring its echotherapy technology to U.S. hospitals and clinical treatment centers. The article reports no financial figures or stock-price impact. https://openbell.ai/news/VIRO:1793952199000 2026-11-06T08:03:19.000Z daily 0.9 https://cdn.brandfetch.io/VIRO/w/400/h/400?c=1idopYfmtR7ZKg8QMud ViroGates Reports Interim Results for Q1-Q3 2026 ViroGates reported revenue of DKK 6.2 million for the first nine months of 2026, up 75% year over year, largely due to a minimum-order delivery from U.S. partner suPARbio in Q2; Q3 revenue was DKK 1.1 million. The company maintained its full-year guidance of DKK 6.5–8 million in revenue and an EBIT loss of DKK 10–12 million. ViroGates is shifting from a sales-driven model toward business development focused on larger, scalable partnerships, reviewing its partner portfolio and planning to replace its “recurring customers” KPI with revenue reporting by product and geography from 2027. https://openbell.ai/news/TPG0:1793952177000 2026-11-06T08:02:57.000Z daily 0.9 https://cdn.brandfetch.io/TPG0/w/400/h/400?c=1idopYfmtR7ZKg8QMud The Platform Group SE & Co. KGaA Reports Nine-Month 2026 Financial Results and Reaffirms Guidance The Platform Group SE & Co. KGaA reported nine-month 2026 GMV of EUR 1,076.9 million, up from EUR 902.1 million a year earlier, and net revenue of EUR 622.7 million, compared with EUR 531.6 million. It cited strong organic growth across 26 industries and said its partner network had grown to more than 17,800. The company reaffirmed 2026 guidance of EUR 1.7 billion in GMV, at least EUR 1.0 billion in net revenue, and adjusted EBITDA of EUR 70 million to EUR 80 million. https://openbell.ai/news/CANDLE.B:1793952177000 2026-11-06T08:02:57.000Z daily 0.9 https://cdn.brandfetch.io/CANDLE.B/w/400/h/400?c=1idopYfmtR7ZKg8QMud Candles Scandinavia Reports Third Quarter 2026 Financial Results Candles Scandinavia AB reported EBITDA of SEK 13 million in the third quarter of 2026, compared with a loss of SEK 3.6 million in the same quarter a year earlier. The results indicate a year-over-year turnaround in operating performance. https://openbell.ai/news/WPTG.B:1793952162000 2026-11-06T08:02:42.000Z daily 0.9 https://cdn.brandfetch.io/WPTG.B/w/400/h/400?c=1idopYfmtR7ZKg8QMud White Pearl Technology Group Reports Record Q3 2026 Revenue White Pearl Technology Group reported record Q3 2026 revenue of SEK 179.1 million, up 36.5% year over year, while EBITDA increased 9.5% to SEK 31.3 million. For the first nine months, revenue rose 32.7% to SEK 482.9 million and EBITDA was SEK 84.8 million. AI and Platforms grew to 27% of Q3 revenue, compared with 20% in Q1. The company is focusing on integrating acquisitions, cross-selling and improving cash generation, and said Aixia is now fully integrated. https://openbell.ai/news/BMC:1793952162000 2026-11-06T08:02:42.000Z daily 0.9 https://cdn.brandfetch.io/BMC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Brock Milton Capital Reports Q3 2026 Interim Results Brock Milton Capital’s managed assets rose 7.4% year over year to SEK 21.7 billion in Q3 2026. Quarterly operating profit and earnings per share declined, which management attributed to higher growth-related expenses. All four of the company’s funds were added to SPP’s regular selection range, while its global small-cap fund performed strongly in the first nine months of the year. https://openbell.ai/news/EQL:1793952150000 2026-11-06T08:02:30.000Z daily 0.9 https://cdn.brandfetch.io/EQL/w/400/h/400?c=1idopYfmtR7ZKg8QMud EQL Pharma Reports Q2 2026/2027 Financial Results EQL Pharma reported a rebound in sales and EBITDA in the second quarter of fiscal 2026/2027, supported by temporary demand following stock-outs and a milestone payment related to Mellozzan. Write-downs weighed on gross margin. Management maintained its full-year growth guidance of 15%, while saying recovery depends on reliable supply chains and better execution of product launches.